Alison Moore is CTO at Allogene Therapeutics, Inc. (ALLO). They have made 18 open-market trades across 2 companies since 2019, most recently 2026-10-12.
CIK 0001754937
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALLO | 672,731 | $881K |
| CDXS | 244,171 | $302K |
| Total | $1.2M |
Shares reported on the most recent Form 4, priced at the 2026-10-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDXS | SELL | 2026-10-12 | 2026-10-14 | $1.36 | $9K | — | — | — |
| CDXS | SELL | 2026-02-06 | 2026-02-09 | $1.31 | $5K | -9.3% | -1.6% | +105.4% |
| CDXS | SELL | 2025-10-13 | 2025-10-15 | $2.51 | $16K | -5.1% | -40.0% | -37.6% |
| ALLO | SELL | 2022-03-15 | 2022-03-17 | $7.63 | $133K | +13.6% | -11.9% | +8.8% |
| ALLO | SELL | 2021-03-15 | 2021-03-17 | $38.14 | $470K | -8.3% | -9.8% | -30.5% |
| ALLO | SELL | 2020-10-12 | 2020-10-13 | $42.00 | $1.5M | -15.9% | -28.5% | -35.2% |
| ALLO | SELL | 2020-10-08 | 2020-10-09 | $41.00 | $1.8M | -16.3% | -32.3% | -32.2% |
| ALLO | SELL | 2020-10-06 | 2020-10-08 | $40.00 | $1.8M | -12.3% | -31.8% | -34.7% |
| ALLO | SELL | 2020-03-16 | 2020-03-18 | $19.19 | $144K | +13.8% | +56.5% | +138.2% |
| ALLO | SELL | 2019-09-18 | 2019-09-18 | $32.13 | $677K | -16.8% | -16.4% | -17.0% |
| ALLO | SELL | 2019-09-17 | 2019-09-18 | $32.11 | $723K | -16.8% | -16.4% | -17.0% |
| ALLO | SELL | 2019-09-16 | 2019-09-18 | $32.00 | $168K | -16.8% | -16.4% | -17.0% |
| ALLO | SELL | 2019-09-16 | 2019-09-18 | $32.11 | $3.0M | -16.8% | -16.4% | -17.0% |
| ALLO | SELL | 2019-07-30 | 2019-07-30 | $29.85 | $353K | +2.1% | -11.1% | -6.4% |
| ALLO | SELL | 2019-07-29 | 2019-07-30 | $29.39 | $700K | +2.1% | -11.1% | -6.4% |
| ALLO | SELL | 2019-07-26 | 2019-07-30 | $29.18 | $385K | +2.1% | -11.1% | -6.4% |
| ALLO | SELL | 2019-07-26 | 2019-07-30 | $29.44 | $2.9M | +2.1% | -11.1% | -6.4% |
| ALLO | SELL | 2019-06-03 | 2019-06-05 | $26.75 | $2.6M | +5.2% | +2.8% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.